Vimarsana
Biggest News Aggregation in the World

Rogerr Gomis News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Rogerr Gomis. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Rogerr Gomis Today - Breaking & Trending Today

Study shows that selection of breast cancer patients for adjuvant bisphosphonate therapy based on Inbiomotion's MAFTEST reduces the risk of death in comparison with current clinical guidance - Vimarsana News

Study shows that selection of breast cancer patients for adjuvant bisphosphonate therapy based on Inbiomotion's MAFTEST reduces the risk of death in comparison with current clinical guidance

Published: July 14, 2022

MAFTEST analyses of the NSABP-B34 and AZURE landmark clinical trials confirmed clinical utility of the MAFTEST for selection of early-stage breast cancer patients that benefit from adjuvant

Source: finanznachrichten.de
Related Topics:
Comunidad Autonoma De CatalunaUnited KingdomRogerr GomisRobert ColemanRoger GomisAlexander Hg PatersonAlexander PatersonResearch ProfessorUniversity Of CalgaryDepartment Of OncologyUniversity Of SheffieldProfessor EmeritusEmeritus Clinical ProfessorExecutive Chairman
Study shows that selection of breast cancer patients for adjuvant bisphosphonate therapy based on Inbiomotion's MAFTEST® reduces the risk of death in comparison with current clinical guidance - Vimarsana News

Study shows that selection of breast cancer patients for adjuvant bisphosphonate therapy based on Inbiomotion's MAFTEST® reduces the risk of death in comparison with current clinical guidance

Published: July 14, 2022

/PRNewswire/ -- Inbiomotion SL, a company developing a unique single-gene-based biomarker for the personalized adjuvant treatment of early-stage (stage I-III)...

Source: prnewswire.com
Related Topics:
Comunidad Autonoma De CatalunaUnited KingdomRogerr GomisRobert ColemanRoger GomisAlexander Hg PatersonAlexander PatersonResearch ProfessorUniversity Of CalgaryDepartment Of OncologyUniversity Of SheffieldProfessor EmeritusEmeritus Clinical ProfessorExecutive Chairman
Inbiomotion's MAF Test® selects breast cancer patients benefitting from adjuvant clodronate, significantly improving their overall survival - Vimarsana News

Inbiomotion's MAF Test® selects breast cancer patients benefitting from adjuvant clodronate, significantly improving their overall survival

Published: September 30, 2021

/PRNewswire/ -- Inbiomotion SL, a company developing a unique single-gene-based biomarker for the personalized adjuvant treatment of early-stage (stage I-III)...

Source: prnewswire.com
Related Topics:
Comunidad Autonoma De CatalunaPeterc LucasAntonioc WolffJean MairetAlexander PatersonEleftheriosp MamounasNorman WolmarkJuan Carlos TerceroLuis Baez DiazKarenm KingStewartj AndersonAdam BrufskyRoger GomisMiguel SampayoAlexander Hg PatersonRogerr GomisMelanie FinniganLouis FehrenbacherResearch ProfessorUniversity Of CalgaryJournal Of The National Cancer InstituteDepartment Of OncologyNational Cancer InstituteEmeritus Clinical ProfessorExecutive Chairman